Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway
DOI:
https://doi.org/10.3329/bjp.v19i3.76379Keywords:
Osteosarcoma, Prednisone, Western blot, Wnt/β-catenin signalingAbstract
Prednisone, a synthetic glucocorticoid, possesses a moderate duration of action in the human body. To investigate the effect of prednisone on osteosarcoma cells in vitro, CCK8, wound healing, Transwell assays, flow-cytometry, western blot, and ELISA were used to measure cell proliferation, cell migration, cell invasion, cell cycle, cell apoptosis, and the key proteins in Wnt/β-catenin pathway. The results showed prednisone could inhibit the proliferation in osteosarcoma cells and exhibit lower proliferation toxicity towards normal bone cells compared to cisplatin by 17.5% (p<0.001). Cell apoptosis was increased by 6.6 and 7.4%, cell migration was decreased to 62.6 and –23.9%, G0/G1 phase cells were increased by 33.0 and 17.9%, and S phase cells were reduced by 29.6 and 18.0% (all p<0.001) in Mg63 and Saos-2 cells respectively after prednisone treatment. The expressions of β-catenin, cMYC, cyclin D1, and MMP7 were also reduced. In conclusion, prednisone inhibits osteosarcoma cells by regulating the Wnt/β-catenin signaling pathway.
Downloads
30
15
References
Abaya R, Jones L, Zorc JJ. Dexamethasone compared to prednisone for the treatment of children with acute asthma exacerbations. Pediatr Emerg Care. 2018; 34: 53-58.
Ahmad N, Abosoudah IF, Sobaihi MM, Algiraigri AH, Roujouleh F, Ghurab F, Chanoine JP. Adrenal function following acute discontinuation of glucocorticoids in children with acute lymphocytic leukemia: A prospective study. Pediatr Hemat Oncol. 2019; 36: 422-31.
Duarte C, Jimeno A, Kessler ER. Abiraterone acetate to treat metastatic castration-resistant prostate cancer in combina-tion with prednisone. Drug Today. 2019; 55: 5-15.
Felten R, Arnaud L. Is it possible to stop glucocorticoids in systemic lupus? Joint Bone Spine. 2020; 87: 528-30.
Gebru MT, Wang HG, Xavier J. Glucocorticoids act synergis-tically with flt3 inhibitors to enhance cell death in flt3 mutant acute myeloid leukemia. Cancer Res. 2020; 80: 630-36.
Gui ZH, Yan H, Wu JF, Zhang MX, Wu AR, He J. Aberrant activation of Wnt/catenin signaling and overexpression of ABCG2 contributes to apoptosis down regulation and tumor progression of high grade ovarian cancer. Acta Biochim Pol. 2021; 68: 127-33.
Hindmarsh PC, Charmandari E. Variation in absorption and half-life of hydrocortisone influence plasma cortisol concen-trations. Clin Endocrinol. 2015; 82: 557-61.
Jiang L, Yang DD, Zhang ZY, Xu LY, Jiang QY, Tong YX , Zheng LZ. Elucidating the role of Rhodiola rosea L in sepsis-induced acute lung injury via network pharma-cology: Emphasis on inflammatory response, oxidative stress, and the PI3K-AKT pathway. Pharm Biol. 2024, 10: 2319117.
Kaedbey R, Reece D, Venner CP, Mccurdy A, Su JD, Chu MC, Louzada M, Jimenez-Zepeda VH, Mian H, Song KV, Sebag M, Stakiw J, White D, Reiman A, Aslam M, Kotb R, Bergstrom D, Gul E, Leblanc R. Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Cana-dian myeloma research group (CMRG) database. Ejhaem 2024; 5: 474-84.
Kaplan D. Regulatory T cells mediate the anti-inflammatory function of glucocorticoids. J Invest Dermatol. 2020; 140: 2098-98.
Kudawara I, Ueda T, Yoshikawa H, Miyama T, Yamamoto T, Nishizawa Y. Inhibition of tumour growth by dexametha-sone in murine osteosarcomas. Eur J Cancer. 2001; 37: 1703-08.
Le LHM, Elqamoudi B, Colon N, Cramond A, Poly F, Ying L, Korolik V, Ferrero RL. Campylobacter jejuni extracellular vesicles harboring cytolethal distending toxin bind host cell glycans and induce cell cycle arrest in host cells. Microbiol Spectrum. 2024; 12: e0323223.
Lei L, Zhang YC, Jian Q, Lei L, Lv N, Williamson RA, Chen P, Zhang D, Hu JS. Resistance of osteosarcoma cells to the proapoptotic effects of carfilzomib involves activation of mitogen activated protein kinase pathways. Exp Physiol. 2021; 106: 438-49.
Li H, Chen HY, Li RL, Xin JJ, Wu SS, Lan J, Xue KY, Li X, Zuo CL, Jiang W, Zhu, L. Cucurbitacin I induces cancer cell death through the endoplasmic reticulum stress pathway. J Cell Biochem. 2019; 120: 2391-03.
Li JP, Zhang F, Li HH, Peng F, Wang Z, Peng H, He JX, Li Y, He L, Wei LQ. Circ_0010220-mediated mir-503-5p/cdca4 axis contributes to osteosarcoma progression tumorigenesis. Gene 2020; 763: 145068.
Liu Z, Tan RJ, Liu YH. The many faces of matrix metallo-proteinase-7 in kidney diseases. Biomolecules 2020; 10: 960.
McMahon SB. Myc and the control of apoptosis. Csh Perspect Med. 2014; 4: a014407.
Montalto FI, De Amicis F. Cyclin D1 in cancer: A molecular connection for cell cycle control, adhesion and invasion in tumor and stroma. Cells-Basel. 2020; 9: 9122648.
Nomden M, Beljaars L, Verkade HJ, Hulscher JBF, Olinga P. Current concepts of biliary atresia and matrix metallo-proteinase-7: A review of literature. Front Med-Lausanne. 2020; 7: 221-31.
Nusse R, Clevers H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell 2017; 169: 985-99.
Pang JM, Huang YC, Sun SP, Pan YR, Shen CY, Kao MC, Wang RH, Wang LH, Lin KT. Effects of synthetic glucocor-ticoids on breast cancer progression. Steroids 2020; 164: 108738.
Puckett Y, Gabbar A, Bokhari AA. Prednisone. San Fran-cisco, StatPearls, 2024.
Shimba A, Ikuta K. Control of immunity by glucocorticoids in health and disease. Semin Immunopathol. 2020; 42: 669-80.
Taves MD, Ashwell JD. Glucocorticoids in T cell develop-ment, differentiation and function. Nat Rev Immunol. 2021; 21: 233-43.
Tchakarska G, Sola B. The double dealing of cyclin D1. Cell Cycle. 2020; 19: 163-78.
Xu QX, He LM, Ma L, Fan L, Yan LH, Zhao XL, Li YY. Linc01410 accelerated the invasion and proliferation of osteosarcoma by sponging mir-3128. Aging-Us. 2020; 12: 24957-66.
Yamamoto T, Nishiguchi M, Inoue N, Goto HG, Kudawara I, Ueda T, Yoshikawa H, Tanigaki Y, Nishizawa Y. Inhibition of murine osteosarcoma cell proliferation by glucocorticoid. Anticancer Res. 2002; 22: 4151-56.
Yang RY, Gao WH, Wang ZB, Jian HY, Peng L, Yu XP, Xue PS, Peng W, Li KX, Zeng PH. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunc-tion via Nrf2/HO-1/GPX4 axis. Phytomedicine 2024; 122: 155135.
Zhang LY, Chen Y, Jia J, Zhu X, He Y, Wu LM. Mir-27a promotes emt in ovarian cancer through active Wnt/β-catenin signalling by targeting foxo1. Cancer Biomark. 2019; 24: 31-42.
Zhang RT, Shi HR, Ren F, Feng W, Cao Y, Li GL, Liu ZY, Ji PC, and Zhang MH. Microrna-338-3p suppresses ovarian cancer cells growth and metastasis: Implication of Wnt/catenin beta and Mek/ Erk signaling pathways (Retraction of vol 38, art No. 494, 2019). J Exp Clin Canc Res. 2024; 43: 168-82.
Zhang Y, Li NJ, Li H, Chen MJ, Jiang W, Guo WH. Thiram, an inhibitor of 11β-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathway. BMC Pharmacol Toxicol. 2023; 24: 258-67.
Zhao CX, He L, Li LJ, Deng FY, Zhang MH, Wang CH, Qiu JL, Gao QQ. Prenatal glucocorticoids exposure and adverse cardiovascular effects in offspring. Front Endocrinol. 2024; 15: 1430334.
Zheng F, Zhong JM, Chen KL, Shi Y, Wang F, Wang SC, Tang S, Yuan XY, Shen ZJ, Tang SS, Xia DJ, Wu YH, Lu WG. PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway. J Exp Clin Cancer Res. 2023; 42: 295.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yo Zhang, Hongmei Zhang, Shanshan Yang, Xiufeng Gao, Wenhao Guo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
